• OPEN AN ACCOUNT
Indian Indices
Nifty
26,068.15 -124.00
(-0.47%)
Sensex
85,231.92 -400.76
( -0.47%)
Bank Nifty
58,867.70 -480.00
( -0.81%)
Nifty IT
36,885.35 -157.95
( -0.43%)
Global Indices
Nasdaq
46,275.21 501.96
(1.10%)
Dow Jones
6,624.30 64.54
(0.98%)
Hang Seng
48,653.14 -1,170.80
(-2.35%)
Nikkei 225
9,535.95 8.30
(0.09%)
Forex
USD-INR
88.50 -0.07
(-0.08%)
EUR-INR
102.33 -0.31
(-0.31%)
GBP-INR
115.99 -0.49
(-0.42%)
JPY-INR
0.57 0.00
(-0.62%)

EQUITY - MARKET SCREENER

Hester Biosciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524669
INE782E01017
409.0776861
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HESTERBIO
49.48
1440.81
EPS(TTM)
Face Value()
Div & Yield %
34.23
10
0.41
 

Board of IRB Infrastructure Developers recommends Second Interim Dividend
Nov 12,2025
IRB Infrastructure Developers announced that the Board of Directors of the Company at its meeting held on 12 November 2025, has recommended a Second Interim Dividend of Rs.0.07 per share (i.e.7%), subject to the approval of the shareholders.